231 related articles for article (PubMed ID: 28417295)
1. Drug-induced pulmonary arterial hypertension: a review.
Garg L; Akbar G; Agrawal S; Agarwal M; Khaddour L; Handa R; Garg A; Shah M; Patel B; Dalal BD
Heart Fail Rev; 2017 May; 22(3):289-297. PubMed ID: 28417295
[TBL] [Abstract][Full Text] [Related]
2. Drugs induced pulmonary arterial hypertension.
Seferian A; Chaumais MC; Savale L; Günther S; Tubert-Bitter P; Humbert M; Montani D
Presse Med; 2013 Sep; 42(9 Pt 2):e303-10. PubMed ID: 23972547
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced pulmonary arterial hypertension: a recent outbreak.
Montani D; Seferian A; Savale L; Simonneau G; Humbert M
Eur Respir Rev; 2013 Sep; 22(129):244-50. PubMed ID: 23997051
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-measured pulmonary artery to aorta ratio and EUTOS score for detecting dasatinib-induced pulmonary arterial hypertension.
Toya T; Nagatomo Y; Kagami K; Yukino M; Yasuda R; Namba T; Ido Y; Kobayashi S; Masaki N; Yada H; Kimura F; Adachi T
Int J Cardiovasc Imaging; 2019 Aug; 35(8):1435-1442. PubMed ID: 30715668
[TBL] [Abstract][Full Text] [Related]
5. Definitions and diagnosis of pulmonary hypertension.
Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
[TBL] [Abstract][Full Text] [Related]
6. [Drug-induced Pulmonary Hypertension - a Current Review].
Günther S; Behr J; Knoop H
Pneumologie; 2016 May; 70(5):320-7. PubMed ID: 27055781
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary arterial hypertension in four patients treated by leflunomide.
Coirier V; Lescoat A; Chabanne C; Fournet M; Coiffier G; Jouneau S; Polard E; Jégo P
Joint Bone Spine; 2018 Dec; 85(6):761-763. PubMed ID: 29329993
[TBL] [Abstract][Full Text] [Related]
8. Drug-associated pulmonary arterial hypertension.
McGee M; Whitehead N; Martin J; Collins N
Clin Toxicol (Phila); 2018 Sep; 56(9):801-809. PubMed ID: 29508628
[TBL] [Abstract][Full Text] [Related]
9. Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead.
de Jesus Perez V; Kudelko K; Snook S; Zamanian RT
Int J Clin Pract Suppl; 2011 Jan; (169):8-10. PubMed ID: 21176010
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension.
Fox BD; Shimony A; Langleben D; Hirsch A; Rudski L; Schlesinger R; Eisenberg MJ; Joyal D; Hudson M; Boutet K; Serban A; Masetto A; Baron M
Eur Respir J; 2013 Oct; 42(4):1083-91. PubMed ID: 23258775
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary hypertension: definition, classification and treatments].
Jutant EM; Humbert M
Biol Aujourdhui; 2016; 210(2):53-64. PubMed ID: 27687597
[TBL] [Abstract][Full Text] [Related]
12. Why there is a need to discuss pulmonary hypertension other than pulmonary arterial hypertension?
Papathanasiou A; Nakos G
World J Crit Care Med; 2015 Nov; 4(4):274-7. PubMed ID: 26557477
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension.
Oliveira RK; Ferreira EV; Ramos RP; Messina CM; Kapins CE; Silva CM; Ota-Arakaki JS
J Heart Lung Transplant; 2014 Feb; 33(2):157-62. PubMed ID: 24268673
[TBL] [Abstract][Full Text] [Related]
14. Role of epidermal growth factor inhibition in experimental pulmonary hypertension.
Dahal BK; Cornitescu T; Tretyn A; Pullamsetti SS; Kosanovic D; Dumitrascu R; Ghofrani HA; Weissmann N; Voswinckel R; Banat GA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2010 Jan; 181(2):158-67. PubMed ID: 19850946
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and classification of pulmonary hypertension].
Montani D; Chaouat A
Presse Med; 2010 Jun; 39 Suppl 1():1S3-15. PubMed ID: 20732615
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Challenge of Group 2 Pulmonary Hypertension.
Naeije R; D'Alto M
Prog Cardiovasc Dis; 2016; 59(1):22-9. PubMed ID: 27195751
[TBL] [Abstract][Full Text] [Related]
17. The role of tyrosine kinase inhibitor "Lapatinib" in pulmonary hypertension.
Alkhatib Y; Albashaireh D; Al-Aqtash T; Awdish R
Pulm Pharmacol Ther; 2016 Apr; 37():81-4. PubMed ID: 26965087
[TBL] [Abstract][Full Text] [Related]
18. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure.
Halpern SD; Taichman DB
Chest; 2009 Jul; 136(1):37-43. PubMed ID: 19255293
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure.
Dickinson MG; Lam CS; Rienstra M; Vonck TE; Hummel YM; Voors AA; Hoendermis ES
Eur J Heart Fail; 2017 Nov; 19(11):1483-1490. PubMed ID: 28948687
[TBL] [Abstract][Full Text] [Related]
20. Definition, classification, and epidemiology of pulmonary arterial hypertension.
Hoeper MM
Semin Respir Crit Care Med; 2009 Aug; 30(4):369-75. PubMed ID: 19634076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
